First-Ever Vaccine for Chikungunya Virus, Ixchiq, Receives Historic Approval from US FDA
The U.S. Food and Drug Administration (FDA) has given its seal of approval for a revolutionary vaccine designed to prevent chikungunya virus infection. The single-dose vaccine, known as Ixchiq, is intended for people at high risk of exposure to the virus, according to a report from US News & World Report. Chikungunya virus, which is […]
Continue Reading